Pricing Log in Create free account
Saturday 17 October 2026 Export PODD’s income statement to Excel — free account

Insulet Corporation

PODD Healthcare Medical Devices

Insulet Corporation’s revenue for fiscal 2025 (year ended December 2025) was $2.7 billion, up 30.7% from fiscal 2024. In the quarter to June 2026, revenue grew 23.5%, EPS grew 328.1%, free cash flow fell 70.5% and total debt fell 32.2%, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for ten consecutive years, operating cash flow growth for three; insiders bought in the last twelve months.

141.10 2.33 +1.68%
Market cap
$9.6B
P/E
26.4×
Fwd P/E
24.7×
Dividend yield
—
F-score
6/9
Altman Z
9.09
Beneish M
−2.59
Dividend safety
n/a
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Insulet Corporation (PODD) P/B ratio

Alert me on P/B ratio

As of 16 October 2026, Insulet Corporation (PODD) trades at a P/B ratio of 6.9×. Over the past ten years it has ranged from 6.4× (September 2026) to 240× (May 2020); the current reading is higher than 1% of that period. That is above the Medical Devices industry median of 2.3× and above the Healthcare sector median of 2.3×.

P/B ratio, daily

Embed this chart

Annual newest first

Period P/B ratio Change
FY2025 13.2× (12.61%)
FY2024 15.1× (24.15%)
FY2023 19.9× (52.27%)
FY2022 41.7× 28.80%
FY2021 32.4× 18.10%
FY2020 27.4× (79.94%)
FY2019 137× 520.91%
FY2018 22.0× (12.82%)
FY2017 25.2× (25.44%)
FY2016 33.9× (46.30%)

Quarterly newest first

Period P/B ratio Change
Jun 2026 7.4× (34.20%)
Mar 2026 11.3× (14.56%)
Dec 2025 13.2× (15.91%)
Sep 2025 15.7× 3.82%
42 more quarters

Against its own ten years

Low 6.4× High 240×
Ten-year median 29.5×
Current reading's percentile 1

P/B ratio against peers

Company P/B ratio
BIO Bio-Rad Laboratories, Inc. compare 1.3×
BIO.B Bio-Rad Laboratories, Inc. compare 1.4×
GMED Globus Medical, Inc. compare 2.2×
SNN Smith & Nephew SNATS, Inc. compare 2.5×
BRKR Bruker Corporation compare 3.5×
HAE Haemonetics Corporation compare 6.4×
PODD Insulet Corporation 6.9×
PEN Penumbra, Inc. compare 8.2×
GKOS Glaukos Corporation compare 14.2×
Medical Devices industry median 2.3×
Healthcare sector median 2.3×
Market median 1.7×

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

More on PODD